These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 33148014)

  • 1. Off-label Use for Direct Oral Anticoagulants: Valvular Atrial Fibrillation, Heart Failure, Left Ventricular Thrombus, Superficial Vein Thrombosis, Pulmonary Hypertension-a Systematic Review.
    Brokmeier H; Kido K
    Ann Pharmacother; 2021 Aug; 55(8):995-1009. PubMed ID: 33148014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: Systematic Review of Current Literature.
    Kajy M; Shokr M; Ramappa P
    Am J Ther; 2020; 27(6):e584-e590. PubMed ID: 30730331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review.
    Owens RE; Kabra R; Oliphant CS
    Clin Cardiol; 2017 Jun; 40(6):407-412. PubMed ID: 28004413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of direct oral anticoagulants for treatment of left ventricular thrombus; a systematic review.
    Kumar D; Warsha FNU; Helmstetter N; Gupta V
    Acta Cardiol; 2021 Oct; 76(8):825-829. PubMed ID: 33970796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease.
    Dawwas GK; Barnes GD
    Curr Cardiol Rep; 2022 Jun; 24(6):731-738. PubMed ID: 35460473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation.
    Jackevicius CA; Lu L; Ghaznavi Z; Warner AL
    Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e007230. PubMed ID: 33541109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Safety and Effectiveness of Direct-Acting Oral Anticoagulants in Patients with Atrial Fibrillation and Coexisting Valvular Heart Disease.
    Hampton ML; Tellor KB; Armbruster AL; Theodos G; Schwarze MW
    Am J Cardiovasc Drugs; 2020 Dec; 20(6):611-617. PubMed ID: 32043243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
    López-López JA; Sterne JAC; Thom HHZ; Higgins JPT; Hingorani AD; Okoli GN; Davies PA; Bodalia PN; Bryden PA; Welton NJ; Hollingworth W; Caldwell DM; Savović J; Dias S; Salisbury C; Eaton D; Stephens-Boal A; Sofat R
    BMJ; 2017 Nov; 359():j5058. PubMed ID: 29183961
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
    Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
    Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Direct Oral Anticoagulants in Patients With Stage 5 or End-Stage Kidney Disease.
    Starr JA; Pinner NA; Mannis M; Stuart MK
    Ann Pharmacother; 2022 Jun; 56(6):691-703. PubMed ID: 34459281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of edoxaban in patients with chronic thromboembolic pulmonary hypertension: protocol for a multicentre, randomised, warfarin-controlled, parallel group trial - KABUKI trial.
    Hosokawa K; Abe K; Kishimoto J; Kobayakawa Y; Todaka K; Tamura Y; Tatsumi K; Inami T; Ikeda N; Taniguchi Y; Minatsuki S; Murohara T; Yasuda S; Fukuda K; Tsutsui H
    BMJ Open; 2022 Jul; 12(7):e061225. PubMed ID: 37070473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Direct Oral Anticoagulants Be Used for Stroke Prevention Among Patients with Valvular Atrial Fibrillation?
    Anderson SL; Marrs JC
    Curr Cardiol Rep; 2019 Aug; 21(10):118. PubMed ID: 31473836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-analysis.
    Mhanna M; Beran A; Al-Abdouh A; Sajdeya O; Abdulsattar W; Srour O; Ayesh H; Alom M; Khuder SA; Hamouda D; Assaly R
    Am J Ther; 2021 Jun; 28(5):e531-e539. PubMed ID: 34491953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Oral Anticoagulants Versus Vitamin K Antagonists for the Treatment of Left Ventricular Thrombus: An Updated Meta-Analysis of Cohort Studies and Randomized Controlled Trials.
    Chen Y; Zhu M; Wang K; Xu Q; Ma J
    J Cardiovasc Pharmacol; 2022 Jun; 79(6):935-940. PubMed ID: 35383658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study.
    Rahme E; Godin R; Nedjar H; Dasgupta K; Tagalakis V
    Thromb Res; 2021 Jul; 203():121-130. PubMed ID: 34000493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of direct oral anticoagulants and warfarin for the treatment of left ventricular thrombus.
    Bass ME; Kiser TH; Page RL; McIlvennan CK; Allen LA; Wright G; Shakowski C
    J Thromb Thrombolysis; 2021 Aug; 52(2):517-522. PubMed ID: 33420896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Left Ventricular Thrombus.
    Willeford A; Zhu W; Stevens C; Thomas IC
    Ann Pharmacother; 2021 Jul; 55(7):839-845. PubMed ID: 33191781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients.
    Kalani C; Awudi E; Alexander T; Udeani G; Surani S
    Hosp Pract (1995); 2019 Oct; 47(4):181-185. PubMed ID: 31580732
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of prognostic impact of anticoagulants in heart failure patients with atrial fibrillation and renal dysfunction: direct oral anticoagulants versus vitamin K antagonists.
    Sakai T; Motoki H; Fuchida A; Takeuchi T; Otagiri K; Kanai M; Kimura K; Minamisawa M; Yoshie K; Saigusa T; Ebisawa S; Okada A; Kitabayashi H; Kuwahara K
    Heart Vessels; 2022 Jul; 37(7):1232-1241. PubMed ID: 35064298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.